Macrogenics (MGNX) Stock Price, Quote, News & History | Benzinga

Macrogenics Inc (MGNX) Stock Price, Quote, News & History

MGNXNASDAQ

Trade with Public

Trade with Public

$4.07

-0.1-2.4%

At close: Aug 19, 5:00 PM EST

$4.07

-0.1-2.4%

Pre-Market: 4:00 AM EST

OverviewNews Earnings Forecast Events Price Targets Financials Sentiment Ownership Compare Options Stock Report

Key Statistics

Open

-

Close

$4.07

Volume / Avg.

33.00 / 897.35K

Day Range

- - -

52 Wk Range

1.29 - 5.08

Market Cap

$259.26M

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

47

Short Interest

11.94%

Days to Cover

9.33

Recent MacroGenics Inc News

Why Harmonic Shares Are Trading Higher By Around 13%; Here Are 20 Stocks Moving Premarket

Harmonic Inc (HLIT) rose in pre-market trading after beating earnings expectations & raising guidance. Other gainers include Buzzfeed, MacroGenics, & SI-Bone.

Avi Kapoor

Why Is MacroGenics Stock Sinking Tuesday?

MacroGenics sees stock decline after FDA places partial clinical hold on Phase 2 LINNET study due to safety concerns.

Vandana Singh

Why AZEK Shares Are Trading Higher By Around 18%; Here Are 20 Stocks Moving Premarket

Avi Kapoor

After Reporting Five Patient Deaths, Data Committee Recommends MacroGenics Halt Prostate Cancer Trial

MacroGenics will discontinue vobra duo for remaining mCRPC participants after five deaths. New data to be presented at ESMO 2024 conference.

Vandana Singh

Pinterest Issues Weak Revenue Forecast, Joins Groupon, O-I Glass And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session

Avi Kapoor

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

-63.72M

Investing Cash Flow (TTM)

-13.08M

Financing Cash Flow (TTM)

60.02M

Free Cash Flow (TTM)

-65.54M

Capital Expenditure (TTM)

-1.82M

Net Change in Cash (TTM)

-16.78M

Analyst Trends and Forecast

1

Mar

2

Apr

1

Aug

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

3.6

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Valuation Metrics

Enterprise Value

$120.09M

PE Ratio (TTM)

-

PE Ratio (FWD)

-

PEG Ratio (TTM)

-

PS Ratio (TTM)

1.47

PB Ratio (TTM)

6.02

Earnings Yield % (TTM)

-39.21%

Earnings Yield % (FWD)

-44.88%

EV / EBITDA (TTM)

-

Price / EBITDA (TTM)

-

Price / Free Cash Flow (TTM)

-

Book Value / Share

$0.67

Company Debt

Total Debt

-

LT Debt

-

LT Debt Issuance (TTM)

-

LT Debt Repayment (TTM)

-

Total Cash

$113.91M

Debt to Equity

0.82

Issuance of Debt (TTM)

-

Repayment of Debt (TTM)

-

Key Statistics

Open

-

Close

$4.07

Volume / Avg.

33.00 / 897.35K

Day Range

- - -

52 Wk Range

1.29 - 5.08

Market Cap

$259.26M

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

47

Short Interest

11.94%

Days to Cover

9.33

About

Sector

Health Care

Industry

Biotechnology

Macrogenics Inc is a clinical-stage biopharmaceutical company focused on developing antibody-based therapeutics for the treatment of cancer. The company is currently developing therapeutics utilizing multiple modalities, including antibody-drug conju...

Show More

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

Q

How do I buy Macrogenics (MGNX) stock?

A

You can purchase shares of Macrogenics (NASDAQ:MGNX) through any online brokerage.

View our list of the best stock brokerages

Q

Who are Macrogenics (MGNX) competitors?

A

Other companies in Macrogenics’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Regeneron Pharmaceuticals Inc (NASDAQ:REGN).

Q

What is the forecast, or price target, for Macrogenics (MGNX) stock?

A

Macrogenics has a consensus price target of $8.00.

Q

What is the current price for Macrogenics (MGNX)?

A

The stock price for Macrogenics (NASDAQ: MGNX) is $4.07 last updated August 20, 2026 at 5:03 PM EDT.

Q

Does Macrogenics (MGNX) pay a dividend?

A

There are no upcoming dividends for Macrogenics.

Q

When is Macrogenics (NASDAQ:MGNX) reporting earnings?

A

Macrogenics does not have any upcoming earnings scheduled.

Q

Is Macrogenics (MGNX) going to split?

A

There is no upcoming split for Macrogenics.

Q

What sector and industry does Macrogenics (MGNX) operate in?

A

Macrogenics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.